Today, weāre diving into an exciting development in obesity treatmentāoral semaglutide. Last week, the FDA approved Novo Nordiskās Wegovy pill as the first and only oral GLP-1 for weight loss in adults. This approval is based on results from the OASIS-4 phase 3 clinical trial showing that a once-daily oral version of semaglutide can deliver […]
semaglutide
GLP-1 Therapies Strategies: Weekly, Micro-Dose, and Maintenance
Today, weāre diving into GLPā1 therapies, including dual GIP/GLPā1 agonists and the emerging triple agonists, and talking about how these peptides are typically dosed, what people are experimenting with, and what the research ā or real-world experience ā tells us so far. Most GLPā1 receptor agonists, as well as dual and triple agonists, are designed […]
A Comprehensive Guide to the Top 27 Peptide Therapies: How They Work, Benefits, and Side Effects
Peptide therapies have become increasingly popular for their ability to treat various health conditions, from improving athletic performance to supporting anti-aging, immune function, and weight loss. Peptides are short chains of amino acids that naturally occur in the body and act as signaling molecules, helping to regulate numerous biological processes. Here, weāll discuss the top […]
Nutrient Tips While on GLPā1 Medications
Today weāre going to talk about something thatās becoming really important for anyone taking medications like Ozempic, Wegovy, or other GLPā1 receptor agonists. You probably already know the benefits of GLP-1sāsmaller appetite, better blood sugar control, and noticeable weight loss. But hereās the catch: eating less can sometimes mean youāre also taking in fewer essential […]
Finding the Right Fit: Semaglutide, Tirzepatide, or Retatrutide
Today, weāre tackling a question that comes up often in peptide, weight loss, and nutrition clinics: why does one person see great results with semaglutide, while another responds better to tirzepatideāor even retatrutide? All three peptides target the incretin system, but they act in slightly different waysāand those differences can dramatically affect outcomes. Letās start […]
GLP-1ās & Addiction
Today weāre talking about peptides being researched for addiction. Weāll unpack the science behind the incretin system, how those pathways tie into reward and substance use, and focus in on the newest tripleāagonist retatrutide. Weāll also look at early evidence for alcohol, tobacco and other substance-use disorders when using certain peptide therapies. What are GLP-1, […]